cas 639090-53-2|| where to buy N-(4-((4,6-Dichloropyrimidin-2-yl)thio)-phenyl)cyclopropanecarboxamide

Nombre del producto:N-(4-((4,6-Dichloropyrimidin-2-yl)thio)-phenyl)cyclopropanecarboxamide

IUPAC Name:N-{4-[(4,6-dichloropyrimidin-2-yl)sulfanyl]phenyl}cyclopropanecarboxamide

Unidad de embalaje	Stock disponible	Precio($)
CM167453-100mg	in stock	Ĳůů
CM167453-250mg	in stock	ȃǤƿ
CM167453-1g	in stock	ƓŹŗ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 639090-53-2 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :639090-53-2; Fórmula molecular:C14H11Cl2N3OS; Punto de fusión:-; Código de sonrisas:O=C(C1CC1)NC2=CC=C(SC3=NC(Cl)=CC(Cl)=N3)C=C2; Densidad:

: Número de catálogo:CM167453; Peso molecular:340.22; Punto de ebullición:; Nº Mdl:MFCD10565704; Almacenamiento:Store at 2-8°C.

: Pyrimidines; Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.

: Cyclopropanes; Cyclopropane is the smallest cyclic compound with unique structural features and physicochemical properties, which is widely used in the design of small molecule drugs. In drug design, it is often used to increase activity, fix conformation and improve PK and water solubility. The introduction of cyclopropyl groups into drugs can change various properties of molecules, such as improving metabolic stability; increasing biological activity; enhancing drug efficacy; limiting polypeptide conformation and slowing down its hydrolysis; reducing plasma clearance; improving drug dissociation and many more. Cyclopropane rings are widely found in marketed drugs, including cardiovascular drugs, central nervous system (CNS) drugs, anticancer drugs, autoimmune and anti-inflammatory drugs.